Factors predicting persistent sputum smear positivity among pulmonary TB patients 2 months after treatment (vol 7, pg 58, 2003)

被引:0
|
作者
Singla, R
Osman, MM
Khan, N
Al-Sharif, N
Al-Sayegh, MO
Shaikh, MA
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:304 / 304
页数:1
相关论文
共 11 条
  • [1] Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment
    Singla, R
    Osman, MM
    Khan, N
    Al-Sharif, N
    Al-Sayegh, MO
    Shaikh, MA
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (01) : 58 - 64
  • [2] Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
    Gatete, Gaetan
    Njunwa, Kato J.
    Migambi, Patrick
    Ntaganira, Joseph
    Ndagijimana, Albert
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [3] Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study
    Gaetan Gatete
    Kato J Njunwa
    Patrick Migambi
    Joseph Ntaganira
    Albert Ndagijimana
    BMC Infectious Diseases, 23
  • [4] Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria
    Ukwaja, Kingsley N.
    Oshi, Daniel C.
    Oshi, Sarah N.
    Alobu, Isaac
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (07) : 431 - 438
  • [5] Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study
    Shariff, Noorsuzana Mohd
    Safian, Nazarudin
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2015, 4 (04) : 323 - 329
  • [6] Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis
    Kang, Hyung Koo
    Jeong, Byeong-Ho
    Lee, Hyun
    Park, Hye Yun
    Jeon, Kyeongman
    Huh, Hee Jae
    Ki, Chang-Seok
    Lee, Nam Yong
    Koh, Won-Jung
    MEDICINE, 2016, 95 (31)
  • [7] Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India (vol 165, pg 278, 2024)
    Pardeshi, P.
    Mave, V
    Gaikwad, S.
    Kadam, D.
    Barthwal, M.
    Gupte, N.
    Atre, S.
    Deshmukh, S.
    Golub, J. E.
    Chest, Gupte A.
    CHEST, 2025, 167 (01) : 296 - 296
  • [8] A time-to-event modelling of sputum conversion within two months after antituberculosis initiation among drug-susceptible smear positive pulmonary tuberculosis patients: Implementation of internal and external validation
    Muda, Mohd Rahimi
    Albitar, Orwa
    Harun, Sabariah Noor
    Sulaiman, Syed Azhar Syed
    Ali, Irfhan Ali Hyder
    Ghadzi, Siti Maisharah Sheikh
    TUBERCULOSIS, 2024, 148
  • [9] Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions (vol 11, pg 46, 2007)
    Jakubowiak, W. M.
    Bogorodskaya, E. M.
    Borisov, E. S.
    Damlova, D., I
    Kourbatova, E. K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (03) : 354 - 354
  • [10] Supportive care needs among head and neck cancer patients in the recovery phase from 6 months to 2 years after treatment: which factors matter?
    Molenaar, D.
    Verdonck-de Leeuw, I. M.
    Lissenberg-Witte, B. I.
    Takes, R. P.
    de Bree, R.
    Langendijk, J. A.
    Hardillo, J. A.
    Lamers, F.
    Leemans, C. R.
    Jansen, F.
    JOURNAL OF CANCER SURVIVORSHIP, 2025,